Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rise in government funding for toxicology research
3.2.1.2 Increased R&D investments
3.2.1.3 Technological advancements
3.2.1.4 Growing resistance against animal testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory restrictions
3.2.2.2 Lack of in-vitro models to study complex end-points
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product and Services, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.3 Assays
5.3.1 Bacterial toxicity assays
5.3.2 Enzyme toxicity assays
5.3.3 Cell-based ELISA and western blots
5.3.4 Receptor binding assays
5.3.5 Tissue culture assays
5.3.6 Others assays
5.4 Equipment
5.5 Software
5.6 Services
Chapter 6 Market Estimates and Forecast, By Endpoint and Test, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Absorption, distribution, metabolism, and excretion (ADME)
6.3 Skin irritation, corrosion, sensitization
6.4 Genotoxicity
6.5 Cytotoxicity
6.6 Ocular toxicity
6.7 Organ toxicity
6.8 Phototoxicity
6.9 Dermal toxicity
6.10 Other endpoints and tests
Chapter 7 Market Estimates and Forecast, By Technology, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Cell culture
7.3 High throughput
7.4 Toxicogenomics
Chapter 8 Market Estimates and Forecast, By Method, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Cellular assays
9.3 Biochemical assays
9.4 In silico models
9.5 Ex vivo models
Chapter 9 Market Estimates and Forecast, By Industry, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceuticals and biopharmaceuticals
8.3 Cosmetics and household products
8.4 Food
8.5 Chemicals
Chapter 10 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.2 Agilent Technologies, Inc.
11.3 Bio-Rad Laboratories, Inc.
11.4 Catalent, Inc.
11.5 Charles River Laboratories International, Inc.
11.6 Danaher Corporation
11.7 Eurofins Scientific
11.8 Evotec S.E.
11.9 Laboratory Corporation of America Holdings
11.10 Merck KGaA
11.11 Quest Diagnostics Incorporated
11.12 SGS Societe Generale de Surveillance SA
11.13 Thermo Fisher Scientific Inc.
